JERUSALEM--(BUSINESS WIRE)--Jun. 5, 2014--
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio
webcast at the Goldman Sachs 35th Annual Global Healthcare
Conference. Eyal Desheh, EVP & CFO will present on Tuesday, June 10,
2014 at 2 PM PT.
|
What:
|
|
Teva Presentation at the Goldman Sachs 35th Annual Global
Healthcare Conference
|
|
|
|
Who:
|
|
Eyal Desheh, EVP & CFO,
|
|
|
|
Teva Pharmaceutical Industries Ltd.
|
|
|
|
When:
|
|
Tuesday, June 10, 2014
|
|
|
|
Where:
|
|
www.tevapharm.com
|
|
|
|
How:
|
|
Live over the Internet – log on to the Web at the address above and
register for the event (approximately 10 minutes before). An archive
of the webcast will be available on Teva’s website.
|
|
|
|
|
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic
drugs as well as innovative and specialty pharmaceuticals and active
pharmaceutical ingredients. Headquartered in Israel, Teva is the world's
leading generic drug maker, with a global product portfolio of more than
1,000 molecules and a direct presence in approximately 60 countries.
Teva's Specialty Medicines businesses focus on CNS, respiratory
oncology, pain, and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 45,000 people around the
world and reached $20.3 billion in net revenues in 2013.
Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
IR:
United States
Kevin
C. Mannix, 215-591-8912
or
Ran Meir, 215-591-3033
or
Israel
Tomer
Amitai, 972 (3) 926-7656
or
PR:
Israel
Iris
Beck Codner, 972 (3) 926-7687
or
United States
Denise
Bradley, 215-591-8974
or
Nancy Leone, 215-284-0213